ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER
Clinical trials for ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Virus therapy trial offers new hope for Tough-to-Treat lung cancer
Disease control Recruiting nowThis study is testing a new two-step treatment for advanced non-small cell lung cancer that has started to grow again after initial therapy. One group receives an intravenous modified virus designed to attack cancer cells, followed by standard chemotherapy and immunotherapy. The …
Matched conditions: ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
New drug targets common cancer driver in first human trial
Disease control Recruiting nowThis is an early-stage study testing a new drug called BGB-53038, which is designed to block a specific protein (KRAS) that drives the growth of many advanced solid tumors. The main goal is to find a safe dose and see how the body handles the drug, both when given alone and when …
Matched conditions: ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC